The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 32 results:
Author Title [ Type(Desc)] Year
Filters: Author is Sardeli, Chrysanthi  [Clear All Filters]
Journal Article
Frøkiaer, J., Li C., Shi Y., Jensen A., Praetorius H., Hansen H., et al. (2003).  Renal aquaporins and sodium transporters with special focus on urinary tract obstruction.. APMIS Suppl. 71-9.
Gkotsos, G., Virgiliou C., Lagoudaki I., Sardeli C., Raikos N., Theodoridis G., et al. (2017).  The Role of Sarcosine, Uracil, and Kynurenic Acid Metabolism in Urine for Diagnosis and Progression Monitoring of Prostate Cancer.. Metabolites. 7(1), 
Sapalidis, K., Sardeli C., Pavlidis E., Koimtzis G., Koulouris C., Michalopoulos N., et al. (2019).  Scar tissue to lung cancer; pathways and treatment.. J Cancer. 10(4), 810-818.
Hohenforst-Schmidt, W., Zarogoulidis P., Steinheimer M., Benhassen N., Sardeli C., Stalikas N., et al. (2017).  Second-line afatinib administration in an elderly patient with squamous cell carcinoma.. Ther Clin Risk Manag. 13, 341-343.
Sapalidis, K., Kosmidis C., Funtanidou V., Katsaounis A., Barmpas A., Koimtzis G., et al. (2019).  Update on current pancreatic treatments: from molecular pathways to treatment. Journal of Cancer. 10(21), 5162 - 5172.
Sapalidis, K., Kosmidis C., Funtanidou V., Katsaounis A., Barmpas A., Koimtzis G., et al. (2019).  Update on current pancreatic treatments: from molecular pathways to treatment.. J Cancer. 10(21), 5162-5172.
Sardeli, C., Axelsen S. M., & Bek K. M. (2005).  Use of porcine small intestinal submucosa in the surgical treatment of recurrent rectocele in a patient with Ehlers-Danlos syndrome type III.. Int Urogynecol J Pelvic Floor Dysfunct. 16(6), 504-5.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.